FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers
about
CIViC databaseInhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationActivation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy.Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal CarcinomaCharacterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaMERTK as a novel therapeutic target in head and neck cancer.Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.Insight into resistance mechanisms of AZD4547 and E3810 to FGFR1 gatekeeper mutation via theoretical study.Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors.A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma.Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma.FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors.Expanding the computational toolbox for interrogating cancer kinomes.Missing the mark in FGFR1-amplified squamous cell cancer of the lung.Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
P2860
Q27612411-AF425614-6320-487E-8469-870F4C21CA38Q28079309-062F3C0B-E997-4379-8DBA-749036EB4EF9Q33586758-56CE7FA3-F9C9-404F-9C06-7B229E92D6E6Q33634701-1BA19CFD-1B9E-40D2-805D-96C90C2551EBQ35837391-E1446A15-0D84-4A1F-A69F-5AEB74055684Q35932114-4AF60F09-B34F-4717-B2C1-ABE2F3656C60Q37067161-D284890B-6647-4E30-A5C4-FE0BB46825C7Q37362739-6CC8F7D8-884F-4D1C-BCEA-1861C71ABC25Q37444264-F20CD5F3-4C6E-4CC8-98E3-0BC3EAFABC83Q37701569-A9ABCD1B-6CA9-41D1-89F9-028FC0745056Q38724189-64843638-3444-4498-A341-C775AC144564Q38756969-FE989863-107B-4B81-908B-3918D3E032C6Q41511970-B08E5CD8-EBE0-411C-8759-76D034667DFFQ42320235-C1C4C6F6-33DD-4204-BD7A-70A819195CC8Q42694284-A6A59D3B-74DD-4282-BD17-9C279E11D62AQ47162061-95863F27-1B27-41CC-9BB6-E854BDBDB051Q47612372-8FB5D42B-638A-4991-8B99-6D18737794E7Q48206952-5A7FAD2B-F148-4039-B4B1-2D342F8BC646Q48564245-CE3118DF-C1E4-4F9D-9CA9-11D3E6624335Q49843607-A98CFD08-28CC-468C-8629-7E10E27F1E35Q51070856-0ED850EC-6240-4B7F-BE4A-3C9B94DF21F8Q52308286-99F30DFE-8F98-41F0-90CB-6A1A9722CB3FQ52863616-0CD7D8A2-09AB-4F04-8E46-4E77C7F96DD3Q53128013-D5BF76F4-BD47-4A8C-A619-15F843126E2FQ54985778-28D7C4C6-84BF-4C02-AF68-298AFF0CC16AQ58780441-5B4AAEAA-789B-4861-9C30-FB25FFE95A80
P2860
FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@ast
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@en
FGFR1 Expression Levels Predic ...... nd Neck Squamous Cell Cancers.
@nl
type
label
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@ast
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@en
FGFR1 Expression Levels Predic ...... nd Neck Squamous Cell Cancers.
@nl
altLabel
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@en
prefLabel
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@ast
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@en
FGFR1 Expression Levels Predic ...... nd Neck Squamous Cell Cancers.
@nl
P2093
P2860
P3181
P1476
FGFR1 Expression Levels Predic ...... and Neck Squamous Cell Cancers
@en
P2093
Alina Franzen
Andreas Schroeck
Anne von Maessenhausen
Antonia Göke
Antonio Jimeno
Brigitte Lankat-Buttgereit
Carsten Golletz
Diana Boehm
Emily K Kleczko
Fred R Hirsch
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-14-3357
P407
P577
2015-05-26T00:00:00Z